Delivery Order SPE2DB22D9101-SPE2DB25FU7KX

Award Date 3/6/25
Potential Completion Date 3/7/25
Potential Value $3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order valued at $1,900.75 issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a specialized pharmaceutical product, to support the medical supply needs of military health facilities. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award of $4,681.55 was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is a delivery order for the product "TYPHIM VI 25 MCG/0.5 ML VIAL 10ML" and has a firm fixed-price pricing type. The contract does not have a set-aside designation and will be performed in Conshohocken, PA, with a completion date of November 19, 2024. DMS Pharmaceutical Group Inc. is a key...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB program. The $1,040.42 contract is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine, to support the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA, valued up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $48,899.74 firm fixed-price delivery order is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, with a period of performance through September 27, 2024. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $20,658.62 contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product, with a period of performance through December 19, 2024. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the delivery of Typhim VI 25 mcg/0.5 mL vial (10 mL) pharmaceutical supplies. The single-award Indefinite Delivery Vehicle (IDV) contract SPE2DB, valued at up to $4,999,999, was awarded by the Defense Logistics Agency (DLA) to provide a broad range of pharmaceutical items to military health facilities globally. This delivery order under the IDV has a firm fixed price of $2,080.84 and a completion...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $76,585.30 contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML 20 DOSE VIAL 10M, a specialized pharmaceutical product. The award is a delivery order under a larger $499,999,999 Indefinite Delivery Contract (IDC) that DMS Pharmaceutical Group holds with the DLA. This IDC enables the...
This federal contract award is a delivery order valued at $11,263.20 issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a specialized pharmaceutical product, with a completion date of December 20, 2024. The award is not associated with a set-aside designation and is a firm fixed-price delivery order. DMS...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, was issued by the Defense Logistics Agency (DLA) on November 5, 2024. The $3,041.20 firm fixed-price delivery order (SPE2DP25F0716) is for the supply of Typhoid VI Polysaccharide (8510999864), a specialized pharmaceutical product. This award is part of a larger $499,999,999 Indefinite Delivery Contract (SPE2DB) held by DMS Pharmaceutical Group with the DLA, which enables the agency to issue delivery...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 4,564,220,848 units of the TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML vaccine. The $1,748.69 delivery order was issued under DMS Pharmaceutical's $4,999,999 indefinite delivery vehicle (IDV) contract SPE2DB with DLA to supply a broad range of pharmaceutical items to U.S. military medical facilities worldwide. This contract award does not...
  • SPE2DB22D9101
    Indefinite Delivery Contract
  • SPE2DB22D9101-SPE2DB25FU7KX
    Delivery Order

This federal contract award, valued at $2,964.00, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The award is a firm fixed-price delivery order for the procurement of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a specialized pharmaceutical product.

The contract has an ultimate completion date of March 7, 2025 and is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that the company holds with the DLA under the SPE2DB program, which enables the DLA to issue firm fixed-price delivery orders for a wide variety of pharmaceutical products.

Generated 6/5/25, 9:46 AM